Fecha de publicación: 28/05/2003 Fuente: WIPO "royal jelly" Use of a composition comprising, as active ingredients, a water- and/or fat-soluble cytosolic extract of pollen and optionally pistils optionally combined with Royal Jelly and Vitamin E for manufacturing of a medicament for the treatment of edema relating to normal hormonal variations in women during fertile, peri-menopausal and post-menopausal age.